GLYCEMIC OUTCOMES OF REAL-WORLD MINIMED™ 780G SYSTEM USERS FROM LATIN AMERICA

被引：0
|
作者：
Castro, M. [1 ]
Van Den Heuvel, T. [2 ]
Arrieta, A. [3 ]
Castaneda, J. [3 ]
Grassi, B. [4 ]
Medina, A. Gomez [5 ]
Calliari, L. E. [6 ]
Denise, F. [7 ]
Raggio, M. [8 ]
Cohen, O. [9 ]
机构：
[1] Medtron LATAM, Diabet, Santiago, Chile
[2] Bakken Res Ctr, Medtron Diabet, Maastricht, Netherlands
[3] Medtron Bakken Res Ctr, Medtron Diabet Emea, Maastricht, Netherlands
[4] Pontificia Univ Catolica Chile, Nutr Diabet & Metab, Santiago, Chile
[5] Hosp Univ San Ignacio, Endocrinol Unit, Bogota, Colombia
[6] Santa Casa Sao Paulo Sch Med Sci, Pediat Endocrinol Unit, Sao Paulo, Brazil
[7] CPCLIN DASA Clin Res Ctr, Dept Diabet, Sao Paulo, Brazil
[8] Hosp Univ Austral, Hosp Materno Infantil Tigre, Buenos Aires, Argentina
[9] Medtron Int Trading Sarl, Medtron Diabet Emea, Tolochenaz, Switzerland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
900
引用
收藏
页码：A108 / A109
页数：2
相关论文
共 50 条
  • [41] Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study
    Perea, Veronica
    Quiros, Carmen
    Herrera-Arranz, Maria Teresa
    Azriel-Mira, Sharona
    Wagner, Ana M.
    Beato-Vibora, Pilar
    Soldevila, Berta
    Barquiel, Beatriz
    Pardo, Rosa Marquez
    Diaz-Soto, Gonzalo
    Picon, Maria Jose
    Colomo, Natalia
    Amigo, Judit
    Climent, Elisenda
    Duran-Martinez, Maria
    Corcoy, Rosa
    Codina, Mercedes
    Cuesta, Martin
    Guedes, Begona Vega
    Vinagre, Irene
    ACTA DIABETOLOGICA, 2024,
  • [42] Safety and Metabolic Outcomes of Medtronic Minimed 780G Initiation at Diagnosis in Children and Adolescents
    Yilmaz, Ugur Cem
    Demir, Gunay
    Kizilay, Deniz Ozalp
    Ozen, Samim
    Goksen, Damla
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 674 - 675
  • [43] USE OF THE MEDTRONIC MINIMED 780G SYSTEM IN PREGNANCY IN TYPE 1 DIABETES
    Gardner, D. S.
    Chandran, S. Rama
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A116 - A116
  • [44] An Evaluation of MiniMed™ 780G System Performance in Childhood: A Single Center Experience from Turkey
    Eviz, Elif
    Mutlu, R. Gul Yesiltepe
    Can, Ecem
    Gokce, Tugba
    Muradoglu, Serra
    Hatun, Sukru
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 172 - 172
  • [45] Failure of MiniMed 780g to maintain glycemic targets in a type1 diabetic on steroid treatment
    Mohana, P.
    Bhat, N. K.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 253 - 253
  • [46] Glycemic control in pediatric patients of a level ii hospital - life before and after MiniMed 780g™
    Albuquerque Costa, A. R.
    Monteiro, J.
    Vieira da Silva, M.
    Laranjo, G.
    Campos, J.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 285 - 285
  • [47] INSULIN REQUIREMENTS FOR BASAL AND AUTO-CORRECTION INSULIN DELIVERY IN MINIMED 780G: A REAL-WORLD DATA OF CHILDREN IN 2 DIFFERENT AGE GROUPS
    Karakusx, K.
    Mutlu, G. Yesiltepe
    Eviz, E.
    Can, E.
    Gokce, T.
    Muradoglu, S.
    Hatun, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A23 - A23
  • [48] Long-term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real-world conditions: The benefits of optimal settings
    Bombaci, Bruno
    Passanisi, Stefano
    Calderone, Marco
    Macri, Fabio
    Lombardo, Fortunato
    Salzano, Giuseppina
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2309 - 2312
  • [49] THE IMPACT OF MINIMED™ 780G INSULIN PUMP SYSTEM - A SINGLE CENTRE PROSPECTIVE STUDY
    Kocsis, G.
    Garam, N.
    Javorfi, T.
    Svebis, M.
    Toth, B.
    Ferenci, T.
    Eigner, G.
    Barkai, L.
    Kovacs, L. A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A70 - A70
  • [50] Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study
    Munda, Ana
    Kovacic, Chiara
    Barlovic, Drazenka Pongrac
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (08)
12345